| Entry |
|
|---|
| Name |
Vadastuximab talirine (USAN) |
|---|
| Efficacy |
Antineoplastic, Anti-CD33 antibody |
|---|
| Type |
Antibody-drug conjugate |
|---|
| Comment |
Treatment of leukemia
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: Ig superfamiy
SIGLEC family
CD33 (SIGLEC3)
D11295 Vadastuximab talirine (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
